Wedbush Weighs in on Nuvation Bio’s Q3 Earnings (NYSE:NUVB)
Nuvation Bio Inc. (NYSE:NUVB – Free Report) – Wedbush lifted their Q3 2025 earnings estimates for Nuvation Bio in a report issued on Wednesday, May 7th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings per share of ($0.18) for the quarter, up from their prior forecast of ($0.20). Wedbush currently has […]
Nuvation Bio Inc. (NYSE:NUVB – Free Report) – Wedbush lifted their Q3 2025 earnings estimates for Nuvation Bio in a report issued on Wednesday, May 7th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings per share of ($0.18) for the quarter, up from their prior forecast of ($0.20). Wedbush currently has […]
